May 14, 2020 / 5:08 AM / 18 days ago

BRIEF-Polyphor Announces Acceptance Of Balixafortide Abstract At ASCO 2020 Virtual Scientific Program

May 14 (Reuters) - POLYPHOR AG:

* POLYPHOR ANNOUNCES ACCEPTANCE OF BALIXAFORTIDE ABSTRACT AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2020 VIRTUAL SCIENTIFIC PROGRAM Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below